--- title: "Tiziana Life Sciences (TLSA) news: offering and Nasdaq notice" url: "https://aibio.space/companies/tiziana-life-sciences/" publisher: "aibio.space (Biotech Investor Relations News)" summary: "TLSA offering and Nasdaq notice news: Tiziana Life Sciences closes $8.8 million registered direct offering at $1.25 per share." --- TLSA Tiziana Life Sciences Ltd NASDAQ · Bermuda # Tiziana Life Sciences (TLSA) news TLSA offering and Nasdaq notice news Distress · 2026-04-30 ## [Tiziana Life Sciences files late-filing notice for its 2025 annual report on Form 20-F](https://aibio.space/news/tiziana-life-sciences-files-late-filing-notice-2025-annual-report-form/) The company says compiling and reviewing the information has imposed time constraints. It undertakes to file no later than 15 days after the original due date. ## Latest Tiziana Life Sciences news 1. 2026-01-16 Financings [Tiziana Life Sciences closes $8.8 million registered direct offering at $1.25 per share](https://aibio.space/news/tiziana-life-sciences-closes-8-8-million-registered-direct-offering-1/) Tiziana Life Sciences Ltd sold 7,040,000 ordinary shares to senior management and existing shareholders without a placement agent. Each share came with a warrant at $1.50. 2. 2025-12-12 Financings [Tiziana Life Sciences files for best-efforts share offering via ThinkEquity](https://aibio.space/news/tiziana-life-sciences-files-best-efforts-share-offering-thinkequity/) The preliminary filing leaves the size and price blank. There is no minimum amount, so the company may sell fewer shares than offered. 3. 2025-03-14 Listings [Tiziana Life Sciences regains compliance with Nasdaq minimum bid price rule](https://aibio.space/news/tiziana-life-sciences-regains-compliance-nasdaq-minimum-bid-price-rule/) The requirement was met on March 12, 2025 after a notice dated January 29, 2025. Nasdaq considers the matter closed. ## Tiziana Life Sciences at a glance - **Ticker**: TLSA - **Listing**: NASDAQ - **Country**: Bermuda ### Related companies - [Altamira Therapeutics](https://aibio.space/companies/altamira-therapeutics/) OTC: CYTOF ### Also on NASDAQ - [Co-Diagnostics](https://aibio.space/companies/diagnostics/) CODX - [20/20 Biolabs](https://aibio.space/companies/20-20-biolabs/) AIDX - [CAMP4 Therapeutics](https://aibio.space/companies/camp4-therapeutics/) CAMP - [Amphastar Pharmaceuticals](https://aibio.space/companies/amphastar-pharmaceuticals/) AMPH - [Coherus Oncology](https://aibio.space/companies/coherus-oncology/) CHRS - [Tilray Brands](https://aibio.space/companies/tilray-brands/) TLRY ## Questions about Tiziana Life Sciences Has Tiziana Life Sciences raised money recently? Our latest story on this, dated Jan 16, 2026: "Tiziana Life Sciences closes $8.8 million registered direct offering at $1.25 per share". The story links the filing or release it is based on. [Read the story](https://aibio.space/news/tiziana-life-sciences-closes-8-8-million-registered-direct-offering-1/). Has Tiziana Life Sciences received a Nasdaq deficiency notice? Our latest story on this, dated Apr 30, 2026: "Tiziana Life Sciences files late-filing notice for its 2025 annual report on Form 20-F". The story links the filing or release it is based on. [Read the story](https://aibio.space/news/tiziana-life-sciences-files-late-filing-notice-2025-annual-report-form/). What is the ticker symbol of Tiziana Life Sciences? Tiziana Life Sciences Ltd trades under the ticker TLSA on NASDAQ. Where is Tiziana Life Sciences listed? Tiziana Life Sciences Ltd is listed on NASDAQ. Our directory also records these other listings: GETTEX:0RP; LS:A3C5SS; LSX:A3C5SS. What is the SEC CIK of Tiziana Life Sciences? The SEC Central Index Key (CIK) for Tiziana Life Sciences Ltd is 1723069. Its filings are on SEC EDGAR. How many shares does Tiziana Life Sciences have outstanding? 120,507,401 shares as of 2025-12-31, per the cover page of its 20-F filed 2026-05-01. Which country or territory is Tiziana Life Sciences listed under? Our directory records Tiziana Life Sciences Ltd under Bermuda. What does Tiziana Life Sciences do? Our directory classifies Tiziana Life Sciences Ltd as: Pharmaceuticals: Major. This is a directory classification, not a description of the pipeline. What is the ISIN of Tiziana Life Sciences? The ISIN recorded for Tiziana Life Sciences Ltd is BMG889121031. Does aibio.space cover Tiziana Life Sciences? aibio.space lists Tiziana Life Sciences Ltd among 2,820 public biotech companies and publishes its news here as stories appear. Where is Tiziana Life Sciences incorporated? SEC records list its state or country of incorporation as D0. What is the latest Tiziana Life Sciences (TLSA) stock news? Our latest story on Tiziana Life Sciences, dated Apr 30, 2026: "Tiziana Life Sciences files late-filing notice for its 2025 annual report on Form 20-F". The company says compiling and reviewing the information has imposed time constraints. It undertakes to file no later than 15 days after the original due date. [Source](https://aibio.space/news/tiziana-life-sciences-files-late-filing-notice-2025-annual-report-form/). Is Tiziana Life Sciences in financial distress? Our latest distress story, dated Apr 30, 2026: "Tiziana Life Sciences files late-filing notice for its 2025 annual report on Form 20-F". The company says compiling and reviewing the information has imposed time constraints. It undertakes to file no later than 15 days after the original due date. [Source](https://aibio.space/news/tiziana-life-sciences-files-late-filing-notice-2025-annual-report-form/). Is Tiziana Life Sciences a smaller reporting company? SEC records list Tiziana Life Sciences Ltd's filer category as: Non-accelerated filer. Where is Tiziana Life Sciences headquartered? SEC records list its business address as 3RD FLOOR, 11-12 ST. JAMES'S SQUARE, LONDON, ENGLAND, United Kingdom, SW1Y 4LB. ## Investor discussion: Tiziana Life Sciences Members talk about Tiziana Life Sciences (TLSA). Reader posts, not aibio.space reporting, and not investment advice. Rules 1. **Securities violations are strictly forbidden.** No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information. 2. **Say whether you hold the stock.** Every post states long, short or no position. 3. **No paid or sponsored posts.** Do not post for anyone who pays or rewards you. 4. **No buy or sell calls and no price targets.** 5. **No accusations of crime or fraud against named people** unless you link a court filing or a regulator's release that makes them. 6. **No personal details and no spam.** No links at all for your first 7 days as a member. Posts that break the rules may be deleted without notice, and the account restricted or closed. See the [terms](https://aibio.space/terms/#discussion) and the [privacy policy](https://aibio.space/privacy/#discussion). ## Capital-markets timeline Financings, listing notices, splits, legal actions and other investor events at Tiziana Life Sciences, newest first. Each line links the filing it comes from. 1. 2026-05-01 Distress Reported substantial doubt about its ability to continue as a going concern. SEC Form 20-F. [Source](https://www.sec.gov/Archives/edgar/data/1723069/000121390026051015/ea0287936-20f_tiziana.htm) 2. 2026-04-30 Distress Told the SEC a periodic report would be filed late. SEC Form NT 20-F. [Source](https://www.sec.gov/Archives/edgar/data/1723069/000121390026050353/ea0288541-nt20f_tiziana.htm) 3. 2026-01-16 Financings Reported a financing. SEC Form 6-K. [Source](https://www.sec.gov/Archives/edgar/data/1723069/000121390026004888/ea027314601ex99-1_tiziana.htm) 4. 2025-12-12 Financings Filed a final prospectus for a securities offering. SEC Form 424B5. [Source](https://www.sec.gov/Archives/edgar/data/1723069/000121390025121308/ea0269465-424b5_tizianalife.htm) 5. 2025-04-30 Distress Told the SEC a periodic report would be filed late. SEC Form NT 20-F. [Source](https://www.sec.gov/Archives/edgar/data/1723069/000121390025037710/ea0240274-nt20f_tiziana.htm) 6. 2025-03-24 Financings Set up an at-the-market program to sell shares over time. SEC Form F-3. [Source](https://www.sec.gov/Archives/edgar/data/1723069/000101376225001691/ea0234691-f3_tizianalife.htm) 7. 2025-03-14 Listings Reported a notice from its stock exchange about continued listing requirements. SEC Form 6-K. [Source](https://www.sec.gov/Archives/edgar/data/1723069/000101376225000330/ea023443701ex99-1_tiziana.htm) 8. 2025-01-31 Listings Reported a notice from its stock exchange about continued listing requirements. SEC Form 6-K. [Source](https://www.sec.gov/Archives/edgar/data/1723069/000121390025008957/ea0229454-6k_tiziana.htm) 9. 2024-11-01 Financings Reported a financing. SEC Form 424B5. [Source](https://www.sec.gov/Archives/edgar/data/1723069/000121390024093087/ea0219489-424b5_tizana.htm) ## Stock chart Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. [Open NASDAQ:TLSA on TradingView](https://www.tradingview.com/symbols/NASDAQ-TLSA/). ## SEC filings and registration - **SEC name**: Tiziana Life Sciences Ltd - **CIK**: 1723069 - **Industry (SIC)**: Pharmaceutical Preparations (2834) - **US tickers**: TLSA (Nasdaq) - **State or country of incorporation**: D0 - **Fiscal year ends**: December 31 - **Filer category**: Non-accelerated filer - **Business address**: 3RD FLOOR, 11-12 ST. JAMES'S SQUARE, LONDON, ENGLAND, United Kingdom, SW1Y 4LB - **Phone**: 0044(0) 207-495-2379 - **Shares outstanding**: 120,507,401 as of 2025-12-31 (20-F filed 2026-05-01) - **Former names**: Tiziana Life Sciences plc ### Recent filings (8-K and 6-K are the company's own announcements) - [6-K](https://www.sec.gov/Archives/edgar/data/1723069/000121390026111173/ea0309141-6k_tiziana.htm) filed 2026-10-21 - [6-K](https://www.sec.gov/Archives/edgar/data/1723069/000121390026110270/ea0308850-6k_tiziana.htm) filed 2026-10-16 - [6-K](https://www.sec.gov/Archives/edgar/data/1723069/000121390026110008/ea0308845-6k_tiziana.htm) filed 2026-10-16 - [6-K](https://www.sec.gov/Archives/edgar/data/1723069/000121390026104868/ea0307188-6k_tiziana.htm) filed 2026-09-30 - [6-K](https://www.sec.gov/Archives/edgar/data/1723069/000121390026103735/ea0306829-6k_tiziana.htm) filed 2026-09-28 - [6-K](https://www.sec.gov/Archives/edgar/data/1723069/000121390026101635/ea0306087-6k_tiziana.htm) filed 2026-09-21 - [6-K](https://www.sec.gov/Archives/edgar/data/1723069/000121390026100742/ea0305816-6k_tiziana.htm) filed 2026-09-17 - [6-K](https://www.sec.gov/Archives/edgar/data/1723069/000121390026092792/ea0303146-6k_tiziana.htm) filed 2026-08-24 Source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001723069), retrieved October 23, 2026. Shares outstanding is the cover-page figure from the latest periodic report. The SEC does not publish share prices. ## Listing details Tiziana Life Sciences Ltd is a public biotech or pharmaceutical company listed on NASDAQ under the ticker TLSA, recorded under Bermuda. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. - **Company**: Tiziana Life Sciences Ltd - **Ticker**: TLSA - **Listing**: NASDAQ - **Country or territory**: Bermuda - **Business scope**: Pharmaceuticals: Major - **ISIN**: BMG889121031 - **Other listed symbols**: GETTEX:0RP; LS:A3C5SS; LSX:A3C5SS - **Last quote in directory**: 2026-10-21 - **Directory source**: [Listing page](https://www.tradingview.com/symbols/NASDAQ-TLSA/) Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. [Tell us about a change](https://aibio.space/reputation/#update). Work at this company? [Claim this page](https://aibio.space/claim/). Published and maintained by aibio.space. Not investment advice. [How we work](https://aibio.space/disclosures/). Who manages this page **This page is managed by aibio.space.** The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. [How we work](https://aibio.space/disclosures/#paid) · [Terms](https://aibio.space/terms/#news) · [Request a correction](https://aibio.space/reputation/#update) --- Source page: https://aibio.space/companies/tiziana-life-sciences/. Facts in aibio.space stories are checked against company filings and releases; opinion is labelled. Cite as: aibio.space, "Tiziana Life Sciences (TLSA) news: offering and Nasdaq notice", 2026-10-31, https://aibio.space/companies/tiziana-life-sciences/